Engineered P450 Enzyme Anchoring in E. coli
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Bacterial host cells like E. coli are unsuitable for expressing cytochrome P450 enzymes due to the absence of electron transfer machinery and translational incompatibility of membrane signal modules, limiting their utility in oxidative chemistry.
Innovation Solution
Engineering P450 enzymes with a deletion of the wild-type N-terminal transmembrane region and addition of a transmembrane domain derived from E. coli inner membrane proteins, such as yhcB, zipA, and waaA, to anchor the enzymes in the inner membrane, reducing cellular stress and improving productivity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If P450 enzymes are expressed in E. coli using wild-type membrane signal modules, then the enzymes can be produced, but the cells experience substantial stress response and productivity is limited
Solution Approach 1:
The patent modifies the membrane signal module parameters by deleting the wild-type P450 N-terminal transmembrane region and replacing it with engineered transmembrane domains from E. coli inner membrane proteins. This parameter change in the protein structure eliminates the harmful stress response while maintaining enzyme functionality, thereby improving host cell productivity.
Solution Approach 2:
The patent extracts and removes the problematic wild-type P450 N-terminal transmembrane region that causes cellular stress. By taking out this specific segment and replacing it with compatible E. coli-derived transmembrane domains, the patent eliminates the harmful effect while preserving the essential P450 enzymatic activity.
2Reliability
If P450 enzymes with wild-type transmembrane regions are expressed in E. coli, then the enzymes can function, but translational incompatibility due to lack of endoplasmic reticulum prevents proper membrane anchoring
Solution Approach 1:
The patent introduces E. coli inner membrane protein transmembrane domains as intermediary elements that bridge the incompatibility between eukaryotic P450 enzymes and bacterial host cells. These intermediary transmembrane domains enable proper membrane anchoring of P450 enzymes in E. coli, solving the translational incompatibility issue while maintaining enzyme reliability.
Solution Approach 2:
The patent applies local quality modification by changing only the N-terminal transmembrane region of the P450 enzyme while preserving the rest of the enzyme's structure and function. This localized modification enables compatibility with E. coli membrane systems without affecting the catalytic activity of the P450 enzyme.
3Productivity
If biosynthetic pathways with P450 enzymes are overexpressed in E. coli, then chemical production increases, but the absence of electron transfer machinery and CPRs limits oxidative chemistry capability
Solution Approach 1:
The patent creates a universal membrane anchoring system by using E. coli inner membrane protein transmembrane domains that can accommodate P450 enzymes from various sources. This multi-functional approach enables E. coli to perform oxidative chemistry functions that were previously exclusive to eukaryotic systems, thereby improving both productivity and reliability.
Data Source
AI summary
The present invention relates to the production of chemical species in bacterial host cells. Particularly, the present invention provides for the production of chemical species in Escherichia coli (E. coli) host cells that functionally express engineered P450 enzymes.